CAS: 314776-92-6 - N-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}naphthalene-2-carboxamide hydrochloride
Formula:C26H32ClN3O2
InChI:InChI=1S/C26H31N3O2.ClH/c1-31-25-11-5-4-10-24(25)29-18-16-28(17-19-29)15-7-6-14-27-26(30)23-13-12-21-8-2-3-9-22(21)20-23;/h2-5,8-13,20H,6-7,14-19H2,1H3,(H,27,30);1H
InChI key:InChIKey=KFWJGUZIZAPFMX-UHFFFAOYSA-N
SMILES:Cl.O=C(NCCCCN1CCN(C=2C=CC=CC2OC)CC1)C=3C=CC=4C=CC=CC4C3
- Synonyms:
- 2-Naphthalenecarboxamide, N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-, monohydrochloride
- 2-naphthalenecarboxamide, N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-, hydrochloride (1:1)
- Bp 897
- N-[4-[4-(2-Methoxyphenyl)-1-piperazinyl]butyl]-2-naphthalenecarboxamide hydrochloride (1:1)
- N-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl}-2-naphthamide hydrochloride (1:1)
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
BP 897 hydrochloride REF: TM-T14767CAS: 314776-92-6 | 99.42% | 36.00 €~2,748.00 € | Tue 10 Dec 24 | |
BP 897 REF: IN-DA00CKVFCAS: 314776-92-6 | 98% | To inquire | Tue 10 Dec 24 | |
BP897 REF: 7W-GL4156CAS: 314776-92-6 | - - - | To inquire | Wed 11 Dec 24 | |
BP897 REF: 3D-PMA77692CAS: 314776-92-6 | Min. 95% | To inquire | Tue 21 Jan 25 |
BP 897 hydrochloride
CAS:314776-92-6
BP 897: potent D3 agonist (Ki: 0.92 nM), weak D2 antagonist (Ki: 61 nM), low …
Formula:
C26H32ClN3O2
Purity:
99.42%
Color and Shape:
Solid
Molecular weight:
454
Ref: TM-T14767
1mg | 36.00 € | ||
5mg | 79.00 € | ||
10mg | 109.00 € | ||
25mg | 212.00 € | ||
50mg | 346.00 € | ||
100mg | 553.00 € | ||
1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: IN-DA00CKVF
1mg | 59.00 € | ||
5mg | 113.00 € | ||
10mg | 138.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
BP897
CAS:314776-92-6
BP897 is a dopamine receptor agonist that binds to the D1 and D2 receptors. BP897 …
Formula:
C26H31N3O2
Purity:
Min. 95%
Molecular weight:
417.54 g/mol
Ref: 3D-PMA77692
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025